Glycogen - PDFSEARCH.IO - Document Search Engine

Glycogen
Results: 481

#	Item
401	United States Court of Appeals For the First Circuit No[removed]IN RE: GENZYME CORP. SECURITIES LITIGATION, Add to Reading List Source URL: www.courthousenews.com Language: English - Date: 2014-06-10 11:20:05 Pharmaceutical sciences Genzyme Sanofi Orphan drugs Glycogen storage disease type II Alglucosidase alfa Prescription Drug User Fee Act Imiglucerase Alpha-galactosidase Medicine Health Food and Drug Administration
402	Combating Rare Diseases in the 21st Century The Orphan Drug Act What is a Rare Disease? Add to Reading List Source URL: www.chi.org Language: English - Date: 2014-02-27 15:16:35 Lipid storage disorders Neurodegenerative disorders Drug discovery Epidemiology Orphan drug Orphan Drug Act Niemann–Pick disease Rare Disease Day Glycogen storage disease type II Health Medicine Rare diseases
403	file:///C:/AP%20Documents/Alan/Me/Dropbox/WebSite/lab/reqs/BxRe Add to Reading List Source URL: neuromuscular.wustl.edu Language: English - Date: 2013-04-06 17:29:18 Staining Biopsy Hepatology Protein methods Integrins Laminin Immunohistochemistry Dystroglycan Glycogen Medicine Biology Anatomy
404	Email: Website: 212 McLeod Street PO Box 2312 Cairns Qld 4870 Add to Reading List Source URL: www.gulf-savannah.com.au Language: English - Date: 2014-05-12 00:57:47 Hepatology Inborn errors of carbohydrate metabolism Glycogen storage disease type I Savannah Georgia Cairns Savannah River Geography of Georgia Geography of the United States Georgia
405	GULF SAVANNAH DEVELOPMENT ENTERS A NEW ERA Welcome to[removed]I hope your festive season went well for you and family. Within all organisations change is inevitable and GSD is no different. To this end GSD is preparing to Add to Reading List Source URL: www.gulf-savannah.com.au Language: English - Date: 2014-05-12 00:50:57 Hepatology Inborn errors of carbohydrate metabolism Glycogen storage disease type I
406	We would like to take this opportunity to provide an important update to the Pompe Community Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2008-11-19 13:27:56 Alglucosidase alfa Glycogen storage disease type II Prescription Drug User Fee Act FDA Fast Track Development Program Genzyme William Canfield Medicine Health Food and Drug Administration
407	Microsoft PowerPoint - PompesRehab-Carter [Read-Only] Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2007-09-13 18:17:02 Rare diseases Lysosomal storage diseases Inborn errors of carbohydrate metabolism Muscular system Glycogen storage disease type II Hepatology Cardiomegaly Mitochondrial disease Duchenne muscular dystrophy Health Anatomy Medicine
408	Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease CRANBURY, N.J., March 8, 2011 /PRNewswire/ -- Amicus Therapeutics (Nasdaq: Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2011-03-08 17:31:25 Medicine Food and Drug Administration Pharmaceutical industry Research Lysosomal storage diseases Glycogen storage disease type II Clinical trial New Drug Application Amyotrophic lateral sclerosis Health Clinical research Rare diseases
409	Amicus Therapeutics Announces Second Quarter 2007 Financial Results Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2011-12-11 11:39:13 Clinical research Lysosomal storage diseases Glycogen storage disease type II Hepatology Enzyme replacement therapy Acid alpha-glucosidase Clinical trial ERT Amyotrophic lateral sclerosis Health Medicine Rare diseases
410	Pompe Program Update March 2, 2009 Supply Update In January 2009, Genzyme notified the Pompe community that we were experiencing a temporary constraint in the global supply of Myozyme® (alglucosidase alfa) produced at t Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2009-03-02 20:03:34 Hepatology Alglucosidase alfa Genzyme Food and Drug Administration William Canfield Medicine Health Glycogen storage disease type II

UPDATE